Editorial: Raising the bar: advancing therapeutic strategies for fighting communicable and noncommunicable diseases.
作者信息
Tanoto Dariel Wilbert, Lee Jia Wen, Chong Yee Kien, Lani Rafidah, Hassandarvish Pouya, Oo Adrian
机构信息
Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore, Singapore.
Retroviral Immunology, The Francis Crick Institute and Department of Medicine, Faculty of Medicine, Imperial College London, London, United Kingdom.
出版信息
Front Pharmacol. 2024 Sep 17;15:1486889. doi: 10.3389/fphar.2024.1486889. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Raising the bar: advancing therapeutic strategies for fighting communicable and noncommunicable diseases.
Front Pharmacol. 2024 Sep 17;15:1486889. doi: 10.3389/fphar.2024.1486889. eCollection 2024.
2
Synergies between Communicable and Noncommunicable Disease Programs to Enhance Global Health Security.
Emerg Infect Dis. 2017 Dec;23(13):S40-6. doi: 10.3201/eid2313.170581.
3
Editorial: Non-communicable diseases; sexual reproductive issues; infectious diseases and health systems challenges.
Afr Health Sci. 2022 Dec;22(4):i-v. doi: 10.4314/ahs.v22i4.1.
4
Editorial: Sexual dimorphism of the immune inflammatory response in infectious and non-infectious diseases, volume II.
Front Immunol. 2023 Nov 30;14:1341365. doi: 10.3389/fimmu.2023.1341365. eCollection 2023.
5
Communicable or noncommunicable diseases? Building strong primary health care systems to address double burden of disease in India.
J Family Med Prim Care. 2019 Feb;8(2):326-329. doi: 10.4103/jfmpc.jfmpc_67_19.
6
Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study.
Lancet Infect Dis. 2021 Aug;21(8):1184-1191. doi: 10.1016/S1473-3099(20)30978-6. Epub 2021 Mar 1.
7
Fighting non-communicable diseases in the COVID-19 era: a catch 22?
Acta Cardiol. 2022 Jun;77(4):366-367. doi: 10.1080/00015385.2021.1887587. Epub 2021 Mar 8.
8
Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
Lancet Glob Health. 2020 Dec;8(12):e1489-e1498. doi: 10.1016/S2214-109X(20)30358-2. Epub 2020 Oct 21.
9
Double burden of noncommunicable and infectious diseases in developing countries.
Science. 2012 Sep 21;337(6101):1499-501. doi: 10.1126/science.1223466.
10
Evolution of non-communicable disease prevention and control in China.
Glob Health Promot. 2019 Dec;26(4):90-95. doi: 10.1177/1757975917739621. Epub 2017 Dec 11.
本文引用的文献
1
Biological synthesis of ursodeoxycholic acid.
Front Microbiol. 2023 Feb 24;14:1140662. doi: 10.3389/fmicb.2023.1140662. eCollection 2023.
2
Updates on Group B Infection in the Field of Obstetrics and Gynecology.
Microorganisms. 2022 Dec 2;10(12):2398. doi: 10.3390/microorganisms10122398.
3
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.
Nature. 2023 Mar;615(7950):134-142. doi: 10.1038/s41586-022-05594-0. Epub 2022 Dec 5.
4
The role of antiviral treatment in the COVID-19 pandemic.
Lancet Respir Med. 2022 Feb;10(2):e18. doi: 10.1016/S2213-2600(22)00011-X. Epub 2022 Jan 13.
5
Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study.
Clin Microbiol Infect. 2021 Apr;27(4):597-602. doi: 10.1016/j.cmi.2020.06.004. Epub 2020 Jun 15.
6
In vitro antimicrobial combination testing of and evolution of resistance to the first-in-class spiropyrimidinetrione zoliflodacin combined with six therapeutically relevant antimicrobials for Neisseria gonorrhoeae.
J Antimicrob Chemother. 2019 Dec 1;74(12):3521-3529. doi: 10.1093/jac/dkz376.
7
Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence.
Eur Respir J. 2017 Nov 16;50(5). doi: 10.1183/13993003.01462-2017. Print 2017 Nov.
8
The Prevention of Early-Onset Neonatal Group B Streptococcal Disease.
J Obstet Gynaecol Can. 2016 Dec;38(12S):S326-S335. doi: 10.1016/j.jogc.2016.09.042. Epub 2017 Jan 4.
9
Vancomycin therapy in critically ill patients on continuous renal replacement therapy; are we doing enough?
Saudi Pharm J. 2015 Jul;23(3):327-9. doi: 10.1016/j.jsps.2014.08.005. Epub 2014 Sep 7.
10
Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.
Ann Pharmacother. 2014 Jan;48(1):107-15. doi: 10.1177/1060028013504087. Epub 2013 Nov 1.
Zotero 插件